Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With Metformin
Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This is a multi-centre, open-label, randomized, parallel trial to investigate the efficacy
and safety profile of saxagliptin and glimepiride treatment in patients with type 2 diabetes
inadequately controlled with metformin monotherapy.
Phase:
Phase 4
Details
Lead Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Collaborators:
Changzhou No.2 People's Hospital Huai'an First People's Hospital Huan'an First People's Hospital Nanjing PLA General Hospital The First Affiliated Hospital of Anhui Medical University The First Affiliated Hospital of Soochow University The First Affiliated Hospital with Nanjing Medical University Wuxi People's Hospital Zhongda Hospital